Liver Cancer News and Research

RSS
Liver cancer is more common in older people. Over half of people newly diagnosed with liver cancer are age 65 and over. Liver cancer is more common in men than in women. Liver cancer rates are highest among Asians and Pacific Islanders, most likely because of higher prevalence of viral Hepatitis infection. Liver cancer rates are lower among whites than Blacks or Asians and Pacific Islanders. At this time, we do not know exactly what causes cancer of the liver. There are several different types of liver cancer. The most common type is associated with long-term excessive alcoholic beverage use, scarring of the liver (cirrhosis), and Hepatitis B virus or Hepatitis C virus infection. Long-term use of anabolic steroids can also increase the risk of getting liver cancer. Smoking is also believed to increase the risk of getting liver cancer.
TREM-1 gene disrupts inflammatory process implicated in liver cancer

TREM-1 gene disrupts inflammatory process implicated in liver cancer

Viewpoints: The importance of hepatitis C testing; Medicaid needs to provide coverage for circumcision

Viewpoints: The importance of hepatitis C testing; Medicaid needs to provide coverage for circumcision

CDC: Baby boomers should be tested for Hep C

CDC: Baby boomers should be tested for Hep C

CDC recommends hepatitis C screening for all patients born from 1945-1965

CDC recommends hepatitis C screening for all patients born from 1945-1965

Carnegie Mellon University awarded CURE grant by the Pennsylvania Department of Health

Carnegie Mellon University awarded CURE grant by the Pennsylvania Department of Health

Prostate cancer cells can be killed by theranostic imaging without harming healthy cells

Prostate cancer cells can be killed by theranostic imaging without harming healthy cells

Two new targets could enhance the body's defenses against West Nile and hepatitis C

Two new targets could enhance the body's defenses against West Nile and hepatitis C

Gluconeogenesis severely compromised in HCC by IL6-Stat3-mediated activation of miR-23a

Gluconeogenesis severely compromised in HCC by IL6-Stat3-mediated activation of miR-23a

Antioxidants and pancreatic cancer risk: an interview with Dr Andrew Hart

Antioxidants and pancreatic cancer risk: an interview with Dr Andrew Hart

EASL calls on the UN to take action to fight against viral hepatitis infection

EASL calls on the UN to take action to fight against viral hepatitis infection

Viral evolution and host protein levels predict rapid disease progression in hepatitis C patients

Viral evolution and host protein levels predict rapid disease progression in hepatitis C patients

Jennerex initiates JX-594 Phase 2 trial in advanced hepatocellular carcinoma

Jennerex initiates JX-594 Phase 2 trial in advanced hepatocellular carcinoma

EMA COMP issues positive opinion to Albireo for A4250

EMA COMP issues positive opinion to Albireo for A4250

Bayer, Onyx and Astellas announce results from Tarceva plus Nexavar Phase 3 trial on HCC

Bayer, Onyx and Astellas announce results from Tarceva plus Nexavar Phase 3 trial on HCC

Bristol-Myers Squibb reports results from brivanib plus sorafenib phase III trial on HCC

Bristol-Myers Squibb reports results from brivanib plus sorafenib phase III trial on HCC

BioAlliance Pharma, Vestiq enter license agreement for Oravig to treat oropharyngeal candidiasis

BioAlliance Pharma, Vestiq enter license agreement for Oravig to treat oropharyngeal candidiasis

High vitamin E intake associated with reduced risk of liver cancer

High vitamin E intake associated with reduced risk of liver cancer

Silymarin does not provide greater benefit for patients with chronic HCV infection

Silymarin does not provide greater benefit for patients with chronic HCV infection

Activating NOTCH and AKT gene may trigger cholangiocarcinoma

Activating NOTCH and AKT gene may trigger cholangiocarcinoma

Hepatitis C levels higher among males and African Americans

Hepatitis C levels higher among males and African Americans

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.